EREM, C. Et Al. 2014. Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.122, no.5 , 295-302.

EREM, C., OZBAS, H. M., NUHOĞLU, İ., DEGER, O., CIVAN, N., & ERSOZ, H. O., (2014). Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.122, no.5, 295-302.

EREM, CİHANGİR Et Al. "Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus," EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.122, no.5, 295-302, 2014

EREM, CİHANGİR Et Al. "Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.122, no.5, pp.295-302, 2014

EREM, C. Et Al. (2014) . "Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus." EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , vol.122, no.5, pp.295-302.

@article{article, author={CİHANGİR EREM Et Al. }, title={Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus}, journal={EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES}, year=2014, pages={295-302} }